Middle East Animal Health Market, By Vaccines

Growth Outlook

• The Middle East Animal Health Market, By Vaccines market is on a steady long-term growth path. Segment value stands at roughly USD 1536 Mn in 2026 and is projected to reach USD 1670 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
• 2027: Live Attenuated Vaccines leads this comparison at 1. 11B USD — 66% of the combined total across all 5 groups shown.
• What the regional split looks like (2026): Live Attenuated Vaccines leads, holding roughly 66% of segment value — the single largest regional share. Inactivated Vaccines is the second-largest contributor. Recombinant Vaccines, DNA Vaccines and Others make up the remainder, in descending order.
• By 2027, Live Attenuated Vaccines alone is expected to reach USD 1110 Mn, with Inactivated Vaccines at USD 346 Mn.

Market Dynamics

2027: Live Attenuated Vaccines leads this comparison at 1.11B USD — 66% of the combined total across all 5 groups shown.

Inactivated Vaccines follows at 346.43M USD, 69% smaller than Live Attenuated Vaccines.

Live Attenuated Vaccines: up 120% over the period, 504.53M USD to 1.11B USD.

Inactivated Vaccines grows to 346.43M USD by 2027, from 177.88M USD in 2018 — 95% up.

Recombinant Vaccines: 59.83M USD in 2018 to 103.98M USD by 2027, up 74%.

DNA Vaccines: 37.19M USD to 63.46M USD, 71% higher by 2027.

Others climbs from 29.11M USD (2018) to 46.13M USD (2027), a 58% gain.

The 5-group total: 808.54M USD in 2018, 1.67B USD by 2027, 107% overall.

How To Compare These 5 Groups

This chart compares 5 series side by side, not one trend over time. Read them against each other — the biggest number in the room is not automatically the most important line to follow.

A group with a small share can still matter most for the story — it is often the rate of change, not the current level, that is worth the closer look.

The most practical way to read this is relative: set the Middle East Animal Health market figures beside other regions or segments of the same market to see where growth is concentrated.

The numbers here come from a market sizing model: historical revenue estimates up to the 2018 base year, then forecasts through 2027 using growth-rate assumptions for each segment. The underlying report explains the methodology in detail.